FDA 510(k) FDA class 2 Substantially Equivalent 🇮🇱 Israel

Biobeat Platform-2 and BB-613WP Patch

K Number: K222010 · Decision Dec 30, 2022
Classifications
1
FEI Numbers
400
Registration Numbers
400
Same Product Code
725
Applicant Total
4
Review Days
176

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Biobeat Platform-2 and BB-613WP Patch
K Number
K222010
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
870.2700
Medical Specialty
Cardiovascular
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Biobeat Technologies , Ltd.
Date Received
July 7, 2022
Decision Date
December 30, 2022
Product Code
DQA
Advisory Committee
Cardiovascular
Review Advisory Committee
CV
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DQA Oximeter

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DQA), ordered by most recent decision date.

View all

Other Clearances by Biobeat Technologies , Ltd.

K Number Device Name
K241066 BB-613-BPM
K212153 Biobeat Platform, BB-613WP Patch
K190792 BB-613WP